Loading…
Yes. Compound lifts, progressive overload. The single highest-evidence longevity intervention.
Strength training 2–3× per week is the highest-effect single intervention on healthspan in the literature.
Our read is Well Supported. The intervention clears a strong evidence base (88/100) with broad agreement among the voices we track (94% consensus). At $40/month and medium effort, lifting 3× per week is one of the more defensible moves on this list — the burden of proof has largely been met.
Pulled the public claims about lifting 3× per week from proponents on file (a tracked voice and a tracked voice) and weighed them against the more cautious voices in the field, then cross-checked each against the primary trial and cohort literature and the prevailing clinical guidance. We grade the claim against what the human evidence actually supports, not against how confidently it is stated.
Downside risk on lifting 3× per week is low at sensible doses, but low risk is not no risk: individual response varies, and a low-risk intervention is still only worth it if the benefit is real.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
A well-powered trial showing the effect fails to hold up, or new safety surveillance that shifts the risk-benefit, would move this verdict.
The effect size is large enough to matter clinically, not just statistically.
Mechanistic and trial evidence converge on a real, replicable effect.
The intervention improves the primary outcome at standard doses in healthy adults.
Mechanistic and trial evidence converge on a real, replicable effect.
The intervention improves the primary outcome at standard doses in healthy adults.
Most of the support comes from short or small studies.
The headline effect shrinks once you account for trial quality.
Most of the support comes from short or small studies.
The headline effect shrinks once you account for trial quality.
Most of the support comes from short or small studies.